Delivery Order SPE2DE24DA017-SPE2D625F41GC

Award Date 1/24/25
Potential Completion Date 1/29/25
Potential Value $7.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Naples, FL 34108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract, valued at $2,146.32, is a Delivery Order with a Fixed Price and Economic Price Adjustment pricing type. It covers the provision of Arthrex's ANGEL PRP Kit (US Tray), a specialized medical device used for the preparation of platelet-rich plasma. Arthrex holds a significant single-award Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract, valued at $7,154.40, is for the delivery of ARTHREX ANGEL PRP Kits, a specialized medical device used in platelet-rich plasma therapy. The contract is a fixed-price with economic price adjustment and does not utilize any set-aside designation, indicating Arthrex's strong competitive position in the...
This is a federal delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $5,365.80 fixed-price contract is for the Arthrex Angel PRP (Platelet-Rich Plasma) Kit, an advanced orthopedic medical device. The contract does not have a set-aside designation, indicating Arthrex's strong competitive position in the open federal market. Arthrex holds a significant single-award...
This federal contract award is for the delivery of Arthrex ANGEL PRP (Platelet-Rich Plasma) Kits to the Defense Logistics Agency's Medical Supply Chain. The total ceiling value of this Delivery Order is $2,861.76. The contract was awarded to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, headquartered in Naples, Florida. Arthrex holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, valued at $471,048,172.66, which...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $4,375.80 fixed-price delivery order is for the Arthrex ANGEL PRP Kit (US Tray), an orthopedic medical device used for preparing platelet-rich plasma. The contract has an ultimate completion date of November 13, 2024 and was awarded on November 7, 2024. This delivery order is part of a larger Indefinite...
This federal contract award, valued at $1,788.60, was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is a delivery order for the ARTHREX ANGEL PRP KIT (US TRAY), a specialized medical device used for the preparation of platelet-rich plasma. Arthrex Inc., a for-profit Subchapter S Corporation, has a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency...
This is a delivery order contract awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The $1,788.60 fixed-price contract with economic price adjustment is for the ARTHREX ANGEL PRP KIT (US TRAY), a specialized medical device used for platelet-rich plasma procedures. The contract has a completion date of January 17, 2025 and was awarded on January 14, 2025. There is no set-aside designation...
This federal contract award, valued at $14,308.80, was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is a Delivery Order (DO) for Arthrex's ANGEL PRP (Platelet-Rich Plasma) Kits, a specialized medical product used in orthopedic procedures. Arthrex holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, valued at $471,048,172.66, which allows...
This federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies, was issued by the Defense Logistics Agency's Medical Supply Chain. The $13,536.60 fixed-price delivery order with economic price adjustment covers a range of specialized orthopedic products and surgical instruments, including the ANGEL PRP Centrifuge system, bone screws, suture anchors, arthroscopes, and platelet-rich plasma kits. This delivery order is part of a larger...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract, a Delivery Order valued at $3,577.20, is for the provision of Arthrex ANGEL PRP Kits, a specialized medical device used for the preparation of platelet-rich plasma. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) that Arthrex holds with the Defense Logistics...
  • SPE2DE24DA017
    Indefinite Delivery Contract
  • SPE2DE24DA017-SPE2D625F41GC
    Delivery Order

This is a delivery order award to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies, under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Medical Supply Chain. The order is for Arthrex's ANGEL PRP (Platelet-Rich Plasma) Kits, valued at $7,154.40. The IDC, identified as SPE2DE24D0020, has a total ceiling value of $471,048,172.66 and runs from June 11, 2024, to September 1, 2029. This contract allows VA medical centers nationwide to acquire Arthrex's innovative orthopedic technologies, including surgical implants, arthroscopic instruments, joint replacement technologies, and specialized surgical instrument systems. The contract is not set aside, indicating Arthrex's strong competitive position in the federal marketplace. To date, Arthrex has received over $550,000 in delivery orders under this IDC, demonstrating its capability to support government healthcare systems with advanced medical technologies.

Generated 4/25/25, 9:45 AM